(Q34109289)

31 July 2017

Overuse of proton pump inhibitors. (English)

1 reference

31 July 2017

Naunton M

1

1 reference

PubMed ID

11123484

31 July 2017

Peterson GM

series ordinal

2

1 reference

PubMed ID

11123484

31 July 2017

Bleasel MD

series ordinal

3

1 reference

31 July 2017

1 October 2000

1 reference

Journal of Clinical Pharmacy and Therapeutics

31 July 2017

1 reference

31 July 2017

25

1 reference

31 July 2017

5

1 reference

31 July 2017

333-340

1 reference

A prospective follow-up study of 5669 users of lansoprazole in daily practice.

31 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2000.00312.X

Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2000.00312.X

Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2000.00312.X

Effect of omeprazole on intragastric bacterial counts, nitrates, nitrites, and N-nitroso compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2000.00312.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2000.00312.X

Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2000.00312.X

Marked increase in gastric acid secretory capacity after omeprazole treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2000.00312.X

Proton pump inhibitors may mask early gastric cancer. Dyspeptic patients over 45 should undergo endoscopy before these drugs are started.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2000.00312.X

Compliance with restrictions on the subsidized use of proton pump inhibitors in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2000.00312.X

Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2000.00312.X

The efficacy of proton-pump inhibitors in acute ulcer bleeding: a qualitative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2000.00312.X

The rise and rise of proton pump inhibitor drugs: Patients' perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2000.00312.X

10.1046/J.1365-2710.2000.00312.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11123484